Program
Preclinical Phase 1 Phase 2 Phase 3 Marketed
AR-67
Planning for next clinical studies with FDA input Preclinical Phase complete
Planning for next clinical studies with FDA input Phase 1 Phase complete
Planning for next clinical studies with FDA input Phase 2 Phase in progress
Planning for next clinical studies with FDA input Phase 3 Phase not started
Planning for next clinical studies with FDA input Marketed Phase not started
Rubitecan/Orathecin Pancreatic Cancer
Reviewing previous Phase III data Preclinical Phase complete
Reviewing previous Phase III data Phase 1 Phase complete
Reviewing previous Phase III data Phase 2 Phase complete
Reviewing previous Phase III data Phase 3 Phase in progress
Reviewing previous Phase III data Marketed Phase not started
Mitozytrex Stomach, pancreatic cancers
Assessing partnering potential and next steps Preclinical Phase complete
Assessing partnering potential and next steps Phase 1 Phase complete
Assessing partnering potential and next steps Phase 2 Phase complete
Assessing partnering potential and next steps Phase 3 Phase complete
Assessing partnering potential and next steps Marketed Phase in progress